retatrutide trials near me Retatrutide, Eli Lilly's next generation of weight loss injections, showed dramatic results in clinical trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight. Eli Lilly's 'triple G' agonist triumphs

The most common side effect by far is nausea

Pre-existing Oral Health Conditions : Individuals with a history of cavities, gum disease, or dry mouth may be at higher risk

And if you are eating less because the medication is doing its job suppressing appetite, you are also getting less fiber, less bulk, and less of the natural stimulation your colon needs to do its work

This strategic positioning allows private label partners to market across multiple consumer segments while maintaining responsible structure-function claim compliance

Normally, doctors start you on a low dose and gradually increase it to curb gastrointestinal side effects